301.00 USD
↘ 6.79 (2.21%)AT CLOSE (11:59 AM EDT)
Krystal Biotech, Inc. Common Stock
KRYSNASDAQ • USD
303.00
↗ 2.00 (0.66%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
303.00
↗ 2.00 (0.66%)
Market: CLOSED
Open?$305.34
High?$312.81
Low?$300.02
Prev. Close?$307.79
Volume?264.5K
Avg. Volume?283.0K
VWAP?$306.97
Rel. Volume?0.93x
Bid / Ask
Bid?$259.09 × 40
Ask?$346.34 × 40
Spread?$87.25
Midpoint?$302.72
Valuation & Ratios
Market Cap?9.1B
Shares Out?29.5M
Float?23.9M
Float %?81.3%
P/E Ratio?40.32
P/B Ratio?7.11
EPS?$7.63
Dividend?0.00%
Ex-Dividend?N/A
Shares of Krystal Biotech, Inc. Common Stock (KRYS) are trading at $300.46. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, KRYS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Themes
Employees
295
Market Cap
8.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-09-20
Address
2100 WHARTON STREET
PITTSBURGH, PA 15203
Phone: (412) 586-5830
PITTSBURGH, PA 15203
Phone: (412) 586-5830
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?83
Short Sent.?34
Piotroski F-Score?4/9Mixed
Altman Z-Score?46.86Safe
Confidence?60%Moderate
Short InterestHigh
Short % of Float?13.30%High
Short Interest?3.2M
Days to Cover?8.0
Free Float23.9M
Avg Daily Volume397.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?9.46Strong
Quick Ratio?9.06Strong
Cash Ratio?4.65Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score39/100
P/E?40.3PRICEY▾
Peers100
S&P18
P/B?7.11FAIR▾
Peers100
S&P26
P/S?21.74HIGH▾
Peers100
S&P3
P/FCF?38.2PRICEY▾
Peers100
S&P18
EV/EBITDA?46.5HIGH▾
Peers100
S&P3
EV/Sales?20.54HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?17.6%STRONG▾
Peers50
S&P61
ROA?16.1%STRONG▾
Peers50
S&P89
Cash Flow & Enterprise
FCF?$237.4M
Enterprise Value?$8.6B
Fundamentals ratios updated end of day